Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | Molecular classification and adjuvant treatment in endometrial cancer

Nicoletta Colombo • 24 Oct 2021
ESGO 2021
Endometrial Cancer Gynecological Cancer

Nicoletta Colombo, MD, PhD, European Institute of Oncology, Milan, Italy & University of Milan-Bicocca, Milan, Italy, discusses how molecular classification techniques are helping to identify patients with endometrial cancer who need or don’t need adjuvant treatment. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Nicoletta Colombo

1:19
Relacorilant + nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
Nicoletta Colombo • 12 Sep 2022
1:57
7-year OS from SOLO1: sustained benefit with maintenance olaparib
Nicoletta Colombo • 12 Sep 2022
1:13
Final OS results from PAOLA-1 evaluating 1L maintenance olaparib plus bevacizumab
Nicoletta Colombo • 12 Sep 2022
7:18
KEYNOTE-826: pembrolizumab + chemotherapy vs placebo + chemotherapy for cervical cancer
Nicoletta Colombo • 24 Oct 2021

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals